Allergy Therapeutics plc (AIM:AGY)

Allergy Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 4, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	657	250	7	134	160	89
Market Cap Growth	175.73%	3402.67%	-94.66%	-16.71%	80.14%	-
Enterprise Value	680	246	2	102	124	60
Last Close Price	0.11	0.05	0.00	0.10	0.12	0.06
PE Ratio	-	-	-	-	55.59	12.62
PS Ratio	11.81	4.53	0.12	1.84	1.90	1.14
PB Ratio	-91.91	67.34	3.45	3.54	3.31	2.03
P/TBV Ratio	-	-	-	4.08	3.67	2.28
P/FCF Ratio	-	-	-	-	26.62	8.71
P/OCF Ratio	-	-	-	-	18.68	7.13
PEG Ratio	-	5.65	5.65	5.65	5.65	5.65
EV/Sales Ratio	12.22	4.46	0.03	1.40	1.47	0.77
EV/EBITDA Ratio	-	-	-	-	20.31	8.45
EV/EBIT Ratio	-	-	-	-	31.62	12.08
EV/FCF Ratio	-21.16	-	-	-	20.60	5.90
Debt / Equity Ratio	-6.23	8.36	17.42	0.28	0.23	0.28
Debt / EBITDA Ratio	-	-	-	-	1.44	1.41
Debt / FCF Ratio	-	-	-	-	1.85	1.19
Asset Turnover	0.78	0.84	0.85	0.90	0.97	1.01
Inventory Turnover	2.15	2.09	2.29	2.09	2.11	2.07
Quick Ratio	1.15	0.93	1.07	1.46	2.46	2.34
Current Ratio	1.60	1.63	1.81	2.35	3.17	3.03
Return on Equity (ROE)	-369.20%	-1392.76%	-216.27%	-31.93%	6.25%	17.35%
Return on Assets (ROA)	-25.11%	-32.61%	-31.48%	-9.60%	2.81%	4.03%
Return on Capital (ROIC)	-48.41%	-58.99%	-50.94%	-14.32%	4.24%	6.50%
Return on Capital Employed (ROCE)	-61.30%	-77.50%	-73.00%	-22.50%	5.60%	7.30%
Earnings Yield	-5.43%	-16.10%	-604.03%	-10.31%	1.80%	7.92%
FCF Yield	-4.89%	-14.23%	-470.51%	-12.76%	3.76%	11.48%
Buyback Yield / Dilution	-180.43%	-458.41%	-4.26%	4.98%	-0.47%	-0.57%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.